|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ARRAY BIOPHARMA INC, S-1/A, EX-23.1, 2000-10-27 |
Next: GREAT BEAR INVESTMENTS INC, 8-K, 2000-10-27 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF ARRAY BIOPHARMA INC., AS AND FOR THE THREE MONTH PERIOD
ENDED SEPTEMBER 30, 2000 (UNAUDITED) AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 9,764,709
<SECURITIES> 594,798
<RECEIVABLES> 1,163,248
<ALLOWANCES> 0
<INVENTORY> 1,943,174
<CURRENT-ASSETS> 14,179,982
<PP&E> 12,185,466
<DEPRECIATION> 1,949,202
<TOTAL-ASSETS> 24,786,704
<CURRENT-LIABILITIES> 6,634,345
<BONDS> 0
0
11,502
<COMMON> 3,902
<OTHER-SE> 14,517,312
<TOTAL-LIABILITY-AND-EQUITY> 24,786,704
<SALES> 0
<TOTAL-REVENUES> 2,761,204
<CGS> 2,407,992
<TOTAL-COSTS> 2,407,992
<OTHER-EXPENSES> 1,701,591
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 173,249
<INCOME-PRETAX> (3,085,843)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,085,843)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,085,843)
<EPS-BASIC> (2.17)
<EPS-DILUTED> (2.17)
</TABLE>
|
|